Literature DB >> 8387126

Third-generation antidepressants.

R M Pinder1, J H Wieringa.   

Abstract

Mesh:

Substances:

Year:  1993        PMID: 8387126     DOI: 10.1002/med.2610130304

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


× No keyword cloud information.
  8 in total

Review 1.  Substrate and drug binding sites in LeuT.

Authors:  Ajeeta Nyola; Nathan K Karpowich; Juan Zhen; Jennifer Marden; Maarten E Reith; Da-Neng Wang
Journal:  Curr Opin Struct Biol       Date:  2010-06-16       Impact factor: 6.809

2.  An improved asymmetric synthetic route to a novel triple uptake inhibitor antidepressant (2S,4R,5R)-2-benzhydryl-5-((4-methoxybenzyl)amino)tetrahydro-2H-pyran-4-ol (D-142).

Authors:  Bhaskar Gopishetty; Sanjib Gogoi; Aloke Dutta
Journal:  Tetrahedron Asymmetry       Date:  2011-05-31

Review 3.  Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.

Authors:  C Sánchez; J Hyttel
Journal:  Cell Mol Neurobiol       Date:  1999-08       Impact factor: 5.046

4.  Antidepressant specificity of serotonin transporter suggested by three LeuT-SSRI structures.

Authors:  Zheng Zhou; Juan Zhen; Nathan K Karpowich; Christopher J Law; Maarten E A Reith; Da-Neng Wang
Journal:  Nat Struct Mol Biol       Date:  2009-05-10       Impact factor: 15.369

5.  Hippocampal MicroRNAs Respond to Administration of Antidepressant Fluoxetine in Adult Mice.

Authors:  Nan Miao; Junghee Jin; Seung-Nam Kim; Tao Sun
Journal:  Int J Mol Sci       Date:  2018-02-27       Impact factor: 5.923

6.  New antidepressants or more of the same?

Authors:  Roger M Pinder
Journal:  Neuropsychiatr Dis Treat       Date:  2007       Impact factor: 2.570

7.  Enhancing central noradrenergic function in depression: is there still a place for a new antidepressant?

Authors:  Roger M Pinder
Journal:  Neuropsychiatr Dis Treat       Date:  2005-03       Impact factor: 2.570

8.  Antidepressant-like activity of YL-0919: a novel combined selective serotonin reuptake inhibitor and 5-HT1A receptor agonist.

Authors:  Hong-xia Chen; Zeng-liang Jin; Li-ming Zhang; Rui Xue; Xiao-dan Xu; Nan Zhao; Zhi-kun Qiu; Xian-wang Wang; You-zhi Zhang; Ri-fang Yang; Yun-feng Li
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.